Colleagues paint a mixed picture of ousted vaccine chief

Deutschland Nachrichten Nachrichten

Colleagues paint a mixed picture of ousted vaccine chief
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 politico
  • ⏱ Reading Time:
  • 59 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 59%

Ousted HHS vaccine expert Rick Bright makes a powerful case against the president, but may be pressed at Thursday’s hearing about his own claims and record

Trump in mid-January were seen as so dire that some Trump aides dismissed them as "alarmist," POLITICO previously reported.

Bright alleges that the department’s top lawyer, Charrow, applied pressure to rush the malaria drugs and was personally involved in writing aspects of the plan — a point backed up by several emails included in his complaint — even asworried about the lack of evidence that the drugs could help treat Covid-19 and the potential risk to patients. According to Bright's lawyers, it was the first time that he recalls the department's top lawyer calling him directly to discuss a drug donation.

Bright’s defenders have acknowledged that he tried to compromise with his bosses over hydroxychloroquine. “I believe this transfer was in response to my insistence that the government invest the billions of dollars allocated by Congress to address the COVID-19 pandemic into safe and scientifically vetted solutions, and not in drugs, vaccines and other technologies that lack scientific merit,” the vaccine expert said in an April 22 statement.

“To the outside, you can’t see what we see working for him,” said one person who worked closely with Bright last year. “We would get yelled at when we didn’t provide him with documents that didn’t exist.”

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

politico /  🏆 381. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Drug treatment a stopgap for vaccine to eradicate COVID-19: Chief scientific officerDrug treatment a stopgap for vaccine to eradicate COVID-19: Chief scientific officerJohnson & Johnson's chief scientific officer said it's unlikely the coronavirus will be eradicated without a vaccine. Dr. Paul Stoffels, appearing on ABC's 'This Week' Sunday, responded to comments from President Donald Trump last week that, 'With or without a vaccine, it&
Weiterlesen »

White House to require staffers to wear masks in West WingWhite House to require staffers to wear masks in West WingPresident Donald Trump continued to paint an improving picture of the coronavirus pandemic Monday even as the threat of the virus hit home inside the White House.
Weiterlesen »

Breaking with Trump, health advisers warn against hasty reopeningBreaking with Trump, health advisers warn against hasty reopeningDr. Leana Wen says the US has “squandered away” time to build up its public health infrastructure amid the coronavirus pandemic. “We are going to see this needless suffering, this needless death, because we are opening too soon.”
Weiterlesen »

What you need to know about coronavirus on Wednesday, May 13What you need to know about coronavirus on Wednesday, May 13The picture of the pandemic painted by scientists during a Senate hearing yesterday is very different to the one being pushed by the White House.
Weiterlesen »

Race for coronavirus vaccine raises eyebrows at efficacy surrounding trialsRace for coronavirus vaccine raises eyebrows at efficacy surrounding trialsHanneke Schuitemaker, Johnson & Johnson Global Head of Viral Vaccine Development, and Dr. Dara Kass, Columbia Univ. Medical Center Associate Professor, join MSNBC's Craig Melvin to discuss the efficacy surrounding various trials and where we are on the time line for an approved vaccine.
Weiterlesen »

Vaccine Maker Moderna Moves to Next Phase of TestingVaccine Maker Moderna Moves to Next Phase of TestingModerna’s COVID-19 Vaccine Moves to Phase 2 Testing, and Gets Fast-Track Approval from the U.S. Government
Weiterlesen »



Render Time: 2025-04-03 08:39:21